Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.

Pemphigus is an autoimmune disease of skin adhesion associated with autoantibodies against a number of keratinocyte antigens, such as the adhesion molecules desmoglein (Dsg) 1 and 3 and acetylcholine receptors. The notion that anti-Dsg antibodies alone are responsible for blisters in patients with pemphigus vulgaris (PV) stems from the ability of rDsg1 and rDsg3 to absorb antibodies that cause PV-like skin blisters in neonatal mice. Here, we demonstrate that PV IgGs eluted from rDsg1-Ig-His and rDsg3-Ig-His show similar antigenic profiles, including the 38-, 43-, 115-, and 190-kDa keratinocyte proteins and a non-Dsg 3 130-kDa polypeptide present in keratinocytes from Dsg 3 knockout mouse. We injected into Dsg 3-lacking mice the PV IgGs that did not cross-react with the 160-kDa Dsg 1 or its 45-kDa immunoreactive fragment and that showed no reactivity with recombinant Dsg 1. We used both the Dsg3(null) mice with a targeted mutation of the Dsg3 gene and the "balding" Dsg3(bal)/Dsg3(bal) mice that carry a spontaneous null mutation in Dsg3. These PV IgGs caused gross skin blisters with PV-like suprabasal acantholysis and stained perilesional epidermis in a fishnet-like pattern, indicating that the PV phenotype can be induced without anti-Dsg 3 antibody. The anti-Dsg 1 antibody also was not required, as its presence in PV IgG does not alter the PV-like phenotype in skin organ cultures and because pemphigus foliaceus IgGs produce a distinct phenotype in Dsg3(null) mice. Therefore, mucocutaneous lesions in PV patients could be caused by non-Dsg antibodies.

[1]  J. Stanley Defective cell-cell adhesion in the epidermis. , 1995, Ciba Foundation symposium.

[2]  Komai,et al.  Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus , 1999, The British journal of dermatology.

[3]  M. Seishima,et al.  Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell datachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C. , 1999, The journal of investigative dermatology. Symposium proceedings.

[4]  J. Schiltz,et al.  Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. , 1976, The Journal of investigative dermatology.

[5]  Elaine Fuchs,et al.  Directed Actin Polymerization Is the Driving Force for Epithelial Cell–Cell Adhesion , 2000, Cell.

[6]  J. Stanley Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. , 1993, Advances in immunology.

[7]  M. A. Robledo,et al.  The calcium-sensitive epitope of pemphigus foliaceus antigen is present on a murine tryptic fragment and constitutes a major antigenic region for human autoantibodies. , 1991, The Journal of investigative dermatology.

[8]  J. Uitto,et al.  Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris , 1997, The Journal of cell biology.

[9]  M. S. Steinberg,et al.  A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. , 1986, Journal of immunology.

[10]  E. Beutner,et al.  Demonstration of Skin Antibodies in Sera of Pemphigus Vulgaris Patients by Indirect Immunofluorescent Staining.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  E. Beutner,et al.  Immunofluorescence Tests , 1985, International journal of dermatology.

[12]  S. Grando,et al.  Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. , 2000, The American journal of pathology.

[13]  T. Nishikawa,et al.  Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1. , 1995, Epithelial cell biology.

[14]  K. Cehrs,et al.  Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes , 1993, The Journal of cell biology.

[15]  T. Mauro,et al.  Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease , 2000, Nature Genetics.

[16]  M. Udey,et al.  Pemphigus--diseases of antidesmosomal autoimmunity. , 1999, JAMA.

[17]  L. Diaz,et al.  Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. , 1995, The Journal of investigative dermatology.

[18]  T. Nishikawa,et al.  Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. , 1998, The Journal of clinical investigation.

[19]  X Ding,et al.  Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. , 1997, The Journal of investigative dermatology.

[20]  J. Sundberg,et al.  Vesicle formation and follicular root sheath separation in mice homozygous for deleterious alleles at the balding (bal) locus. , 1997, The Journal of investigative dermatology.

[21]  D. Swanson,et al.  Methylprednisolone inhibits pemphigus acantholysis in skin cultures. , 1983, The Journal of investigative dermatology.

[22]  M. Amagai Adhesion molecules. I: Keratinocyte-keratinocyte interactions; cadherins and pemphigus. , 1995, The Journal of investigative dermatology.

[23]  T. Nishikawa,et al.  The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. , 1999, Journal of the American Academy of Dermatology.

[24]  Zhi Hong Wang,et al.  Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. , 1999, The Journal of clinical investigation.

[25]  J. Stanley Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. , 1989, The Journal of clinical investigation.

[26]  R. F. Johnston,et al.  Autoradiography using storage phosphor technology , 1990, Electrophoresis.

[27]  S. Grando Biological functions of keratinocyte cholinergic receptors. , 1997, The journal of investigative dermatology. Symposium proceedings.

[28]  T. Nishikawa,et al.  Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. , 1997, Journal of immunology.

[29]  P. Lenz,et al.  Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. , 1999, Archives of dermatology.

[30]  D. Kelsell,et al.  N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. , 1999, Human molecular genetics.

[31]  M. Mahoney,et al.  Explanation for localization of blisters in pemphigus patients , 1998 .

[32]  M. Yaar,et al.  Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. , 1982, The Journal of clinical investigation.

[33]  G. Lazarus,et al.  Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Amagai,et al.  Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. , 1992, The Journal of clinical investigation.

[35]  T. Nishikawa,et al.  Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. , 1994, The Journal of clinical investigation.

[36]  J. Caulfield,et al.  An electron microscopic study of acantholysis in pemphigus vulgaris. , 1961, The Journal of investigative dermatology.

[37]  Masayuki Amagai,et al.  Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion , 1991, Cell.

[38]  E. Fuchs,et al.  Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation , 1996, The Journal of cell biology.

[39]  S. Grando,et al.  Pemphigus Vulgaris Antibody Identifies Pemphaxin , 2000, The Journal of Biological Chemistry.

[40]  S. Grando Autoimmunity to Keratinocyte Acetylcholine Receptors in Pemphigus , 2000, Dermatology.

[41]  T. Nishikawa,et al.  Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. , 1990, The Journal of investigative dermatology.

[42]  C. Thivolet,et al.  Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. , 1984, The Journal of clinical investigation.

[43]  S. Grando,et al.  Activation of keratinocyte muscarinic acetylcholine receptors reverses pemphigus acantholysis , 1993 .

[44]  Y. Takahashi,et al.  Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. , 1984, The Journal of investigative dermatology.

[45]  M. Mahoney,et al.  Postnatal lethality of P-cadherin/desmoglein 3 double knockout mice: demonstration of a cooperative effect of these cell adhesion molecules in tissue homeostasis of stratified squamous epithelia. , 2000, The Journal of investigative dermatology.

[46]  L. Diaz,et al.  Pemphigus foliaceus sera recognize an N-terminal fragment of bovine desmoglein 1. , 1994, The Journal of investigative dermatology.

[47]  J. Benz,et al.  Annexins: from structure to function. , 1997, Biological chemistry.

[48]  T. Nishikawa,et al.  Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. , 1996, The Journal of investigative dermatology.

[49]  T. X. Lee,et al.  The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. , 1998, Archives of dermatology.

[50]  J. Zone,et al.  Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. , 1993, The Journal of investigative dermatology.

[51]  J. Voorhees,et al.  Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. , 1982, The New England journal of medicine.

[52]  J. Stanley,et al.  Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. , 1988, The Journal of clinical investigation.

[53]  Y. Aoyama,et al.  Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. , 1999, The Journal of investigative dermatology.

[54]  N. Craddock,et al.  Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease , 1999, Nature Genetics.

[55]  Y. Aoyama,et al.  A pathogenic autoantibody, pemphigus vulgaris‐IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes , 1999, European journal of immunology.

[56]  T. Nishikawa,et al.  Immunoblot assay as an aid to the diagnoses of unclassified cases of pemphigus. , 1991, Archives of dermatology.

[57]  C. Zouboulis,et al.  Storage phosphor imaging technique improves the accuracy of RNA quantitation using 32P-labeled cDNA probes. , 1994, BioTechniques.

[58]  N. Korman,et al.  Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. , 1989, The New England journal of medicine.

[59]  T. Nishikawa,et al.  Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. , 1995, The Journal of investigative dermatology.

[60]  W. Xue American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. Pemphigus vulgaris IgG regulates expression of urokinase receptor and junctional proteins that may contribute to acantholysis. , 1999, Journal of the American Academy of Dermatology.

[61]  L. Diaz,et al.  The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. , 1999, The Journal of investigative dermatology.